medigraphic.com
ISSN 1729-519X (Print)

2019, Number 4

<< Back Next >>

Revista Habanera de Ciencias Médicas 2019; 18 (4)

History of bacterial meningitis in Cuba: From 19th to 21st centuries

Batlle AMC, Dickinson MFO

Language: Spanish
References: 42
Page: 579-592
PDF size: 630.47 Kb.


ABSTRACT

Introduction: Bacterial meningitis remains an important health problem worldwide. In Cuba, there are limited research studies about this issue from a historical perspective.
Objective: To describe the behavior of this disease in Cuba (19th-21st centuries).
Material and Methods: A descriptive historical study was carried out between the ends of 1800- 2017, using the historical-logical method and a deductive-inductive analysis of multiple bibliographical sources.
Development: The first reference to bacterial meningitis in Cuba was made in 1877. The probable introduction of the disease by the US occupation army in 1899 is also considered. In 1901, the meningococci of Weichselbaum was isolated from cerebrospinal fluid, which was probably it first report in Cuba. At the beginning of the 20th century, isolated cases and outbreaks were reported until 1976, when the biggest and larger invasive meningococcal disease began (serogroups C, B). Vaccination against serogroup C started in 1979. In 1980, a special epidemiological surveillance was implemented. The Cuban vaccine VA-MENGOC-BC® against the disease was developed in 1984, which was massively used in 1987. The vaccine contributed to the control of the disease and was included in the National Immunization Program in 1991. Haemophilus Influenzae became the main causative bacterial agent of meningitis until 1999, when the implementation of massive vaccination (Vaxem-Hib® and QuimiHib®) controlled disease. Up to the present, its ecological niche is occupied by pneumococci.
Conclusions: From the end of the 19th century to the second half of the 20th century, bacterial meningitis in Cuba behaved as isolated cases and outbreaks. Effective preventive strategies were implemented during and after a huge epidemic, including Cuban vaccines against the disease, that pass on its behavior to a very low endemic disease up to the moment.


REFERENCES

  1. Tebruegge M, Curtis N. Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis. ClinMicrobiol Rev. [Internet]. 2008 [cited: may 30 2019]; 21(3):519- 37. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C2493086/pdf/0009-08.pdf

  2. Bonthius DJ, Bahri K. Meningitis and encephalitis in children: an update. NeurolClin N Am. 2002; 20:1013-38.

  3. Bruzzone R, Dubois-Dalcq M, Grau GE, Griffin DE, Kristensson K. Infectious diseases of the nervous system: pathogenesis and worldwide impact. BMC Proceedings [Internet]. 2008 [cited: may 30 2019]; 2(Suppl 1):1. Available from: http://www.biomedcentral.com/1753- 6561/2/S1/I1

  4. Laguna del Estal P, García-Montero P, Agud- Fernández M, López-Cano M, Castañeda-Pastor A, García-Zubiri C. Meningitis bacteriana por bacilos gramnegativos en adultos. Rev Neurol. 2010; 50:458-62.

  5. Heyman D. El control de las enfermedades transmisibles. 18ª ed. Washington, D.C.: OPS; 2005.

  6. KwangSik K. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci [Internet].2003 [cited: may 30 2019]; 4(5):376-385. Available from: https://www.nature.com/articles/nrn1103

  7. Costerus JM, Brouwer MC, Bijlsma MW, van de Beek D. Community-acquired bacterial meningitis. CurrOpin Infect Dis[Internet]. 2017[cited: may 30 2019]; 30:135–141. Available from: https://insights.ovid.com/pubmed?pmid=27828 810

  8. Bovell F, Embree J. Bacterial meningitis. Curr Treat Options Infect Dis. 2002; 4:485-90.

  9. Uitterwijk A, Koehler PJ. A history of acute bacterial meningitis. J Hist Neurosci[Internet]. 2012 [cited: may 30 2019]; 21(3):293-313. Available from: https://www.tandfonline.com/doi/abs/10.1080/ 0964704X.2011.595653?journalCode=njhn20

  10. Attia J, Hatala R, Cook DJ, Wong JG. The rational clinical examination: does this adult patient have acute meningitis? JAMA[Internet]. 1999[cited: may30 2019]; 282(2):175-81. Available from: https://jamanetwork.com/journals/jama/articleabstract/ 774331

  11. Vieusseaux M. Mémoire sur la maladie qui a regné a Génève au printemps de 1805. J Med ChirPharmacol. 1805; 11:163-82.

  12. Weichselbaum A. Ueber die Aetiologie der akuten meningitis cerebrospinalis. FortschrMed. 1887; 5:573-88.

  13. Henrichsen J. Typing of Streptococcus pneumoniae: Past, Present, and Future. Am J Med [Internet].1999[cited: may 30 2019];107(1A):50-4. Available from: https://www.amjmed.com/article/S0002- 9343%2899%2900100-X/fulltext

  14. Norskov-Lauritsen N. Classification, Identification, and Clinical Significance of Haemophilusand AggregatibacterSpecies with Host Specificity for Humans. ClinMicrobiol Rev [Internet]. 2014[cited: may 30 2019]; 27(2):214- 240. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C3993099/

  15. Tyler KL. A history of bacterial meningitis. In: Aminoff MJ, Boller F, Swaab DE, Editors. Handbook of Clinical Neurology. 3rd ed. Amstredam: Elsevier; 2010. p. 18-22.

  16. Flexner S. The results of serum treatment in thirteen hundred cases of epidemic meningitis. J Exp Med. 1913:553-76.

  17. Borchardt JK. The history of bacterial meningitis treatment. Drug News Perspect[Internet]. 2004[cited: may 30 2019]; 17(3):219-224. Available from: https://journals.prous.com/journals/servlet/xml xsl/pk_journals.xml_summaryn_pr?p_JournalId= 3&p_RefId=468

  18. Taha MK, Deghmane AE. New recombinant vaccines for the prevention of meningococcal B disease. VaccDev Therapy[Internet]. 2012[cited: may 30 2019]; 2:15-22. Available from: https://www.dovepress.com/new-recombinantvaccines- for-the-prevention-of-meningococcalb- disease-peer-reviewed-article-VDT

  19. Dickinson FO, Rodríguez M. Morbilidad por meningitis bacteriana adquirida en la comunidad, Cuba, 1998-2014. Rev Cubana HigEpidemiol [Internet]. 2019 [consultado: 30 de mayo 2019];55(3). Disponible en: http://www.revepidemiologia.sld.cu/index.php/ hie/article/view/208/232#f01_208_1416

  20. Valcárcel M, Rodríguez CR, Molinert HT. La enfermedad meningocóccica en Cuba: cronología de una epidemia. La Habana: Editorial Ciencias Médicas; 1991.

  21. González del Valle A. Aspectos sanitarios de la población de la Habana. Anales de la Real Academia de Ciencias Físicas y Naturales de la Habana. 1877; Tomo XIV: 98-118.

  22. Recio A. Consideraciones sobre la Meningitis Cerebro Espinal. Anales de la Academia de Ciencias de la Habana. 1925; Tomo LXII:122-35.

  23. Silverio N. Meningitis meningocócica. Archivos de la policlínica. 1899; VII:34-45.

  24. Cartaya J, Recio A. Diagnóstico de la Meningitis Cerebro Espinal. Revista de Medicina y Cirugía de la Habana. 1916; XXI:21- 34.

  25. Acevedo R, Bai X, Borrow R, Caugant DA, Carlos J, Ceyhan M,et al. The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev Vaccines. 2019; 18(1):15-30.

  26. Greenwood B. Pneumococcal Meningitis Epidemics in Africa. Clin Infect Dis.[Internet]. 2006[cited may 30 2019]; 43(6):701-3.Available from: https://academic.oup.com/cid/article/43/6/701 /326807

  27. Tam PYI, Thielen BK, Obaro SK, Brearley AM, Kaizer AM et al. Childhood pneumococcal disease in Africa – a systematic review and meta-analysis of incidence, serotype distribution, and antimicrobial susceptibility. Vaccine [Internet]. 2017[cited: may 30 2019]; 35(15):1817-27. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PM C5404696/

  28. Martínez M. Diagnóstico bacteriológico de la Meningitis Cerebro Espinal Epidémica. Anales de la Academia de Ciencias de la Habana. 1920-21; Tomo LVII:78-104.

  29. Le Roy J, de la Torre C. La constitución médica reinante en esta capital. Anales de la Academia de Ciencias de la Habana. 1925; Tomo LXII:213- 44.

  30. Dickinson FO, Rodríguez M. Epidemiología de la meningitis neumocócica en niños cubanos menores de 6 años. Rev Cubana Pediatr [Internet]. 2017 [consultado: 30 de mayo 2019];89(0). Disponible en: http://www.revpediatria.sld.cu/index.php/ped/ article/view/158

  31. Dickinson F, Rodríguez M, Toraño G. Pneumococcal meningitis in Cuban children and adolescents: A fifteen years follow up. Pediatr. Res. Int. J. [Internet] 2015 [consultado: 30 de mayo 2019]; 89. Disponible en: https://ibimapublishing.com/articles/PRIJ/2015/ 596251/596251.pdf

  32. Martínez JA. Estudio bacteriológico de 340 casos de meningitis purulenta en la infancia. Rev Cubana LabClín. 1948; 12:257-70.

  33. Lobo GE, Dickinson FO, Pérez AE, Vega B, Rodríguez M. Factores asociados con la mortalidad por meningitis neumocócica en hospitales de La Habana. Rev Cubana MedTrop [Internet]. 2013 [consultado: 30 de mayo 2019]; 65(3). Disponible en: http://bvs.sld.cu/revistas/mtr/vol65_3_13/mtr1 0313.htm

  34. Córdova L. Meningoencefalitis purulenta: estudio clínico y etiológico [tesis de Especialista de Primer Grado en Pediatría]. La Habana: Hospital Pediátrico William Soler; 1972.

  35. Quintana I, Sotolongo F, Llop A, Cuevas I, Martínez N, Velázquez JC, et al. Programa nacional de prevención y control de los síndromesneurológicos infecciosos. La Habana: MINSAP; 1999.

  36. Pérez A, Dickinson F, Baly A, Martínez R. The epidemiological impact of antimeningococcal B vaccination in Cuba. Men InstOswaldo Cruz[Internet]. 1999[cited: may 30 2019]; 94(4):433-40. Available from: https://pdfs.semanticscholar.org/1c9a/b9c0024 805b3d4e5e23743327bcc8d744139.pdf

  37. Pérez AE, Dickinson FO, Rodríguez M. Community acquired bacterial meningitis in Cuba: a follow up of a decade. BMC Infectious Diseases[Internet].2010 [cited: may 30 2019];10:130. Available from: http://www.biomedcentral.com/1471- 2334/10/130

  38. Dickinson FO, Pérez AE. Meningoencefalitis bacterianas en Cuba. Rev Cubana HigEpidemiol. 2001; 39 (2):86-94.

  39. Dickinson F, Pérez A, Galindo MA, Quintana I. Impacto de la vacunación contra Haemophilus influenzae tipo b en Cuba. Rev Panam Salud Pública. 2001; 10(3):169-74.

  40. García JR, Baldoquin W, Rodríguez M, Dickinson FO. Haemophilus influenzaemeningitis in Cuban children: a nineteen years follow up. J Pediatr Neonatal Care [Internet]. 2018 [cited: may 30 2019]8(3). Available from: https://medcraveonline.com/JPNC/JPNC-08- 00324

  41. López L, Egües LI, Pérez A, Galindo BM, Galindo MA, ResikS, et al. Experiencia cubana en inmunización, 1962–2016. Rev Panam Salud Pública [Internet]. 2018[consultada: 30 de mayo 2019];42:e34. Disponible en: http://iris.paho.org/xmlui/bitstream/handle/123 456789/34905/v42e342018.pdf?sequence=1&is Allowed=y

  42. Dotres CP, Puga R, Ricardo Y, Broño CR, Paredes B, Echemendía V, et al. Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: A randomized phase I clinical trial. Vaccine. 2014; 32:5266-70.




2020     |     www.medigraphic.com